Arvelo ÁFA, Cotte C, Pérez P, Sojo F

Language: Spanish
References: 14
Page: 748-754
PDF size: 261.52 Kb.

ABSTRACT

Ulcers of the lower extremities have high prevalence and incidence. Their chronicity and frequent recurrences are two of their most important characteristics. Despite proper etiologic treatment and the great variety of dressings available, the healing rate and recovery speed remain low. Therefore, we conducted a study to obtain skin substitutes for clinical application by isolating and cultivating keratinocytes, which were seeded on a fibroblast-containing fibrin gel at high density. Hence, a new practical and inexpensive skin equivalent of straightforward and easy-to-perform transplantation was developed. Before starting the clinical trials to evaluate its advantages and applicability, we conducted a preliminary test to determine if the changes to the standard technique affected its feasibility and action. For this purpose, we implanted the new equivalents into six patients with chronic ulcers unresponsive to treatment. Outcomes in these patients showed that skin equivalents were feasible, effective, easy to handle and had rapid action on target tissues. All patients who completed the procedure recovered. An excellent example was a patient with a chronic lesion refractory to multiple conventional treatments that had been present for six months.

REFERENCES

1. Liu Y, Margolis D, Isseroff R. Does inflammation have a role in the pathogenesis of venous ulcers? A critical review of the evidence. J Invest Dermatol. 2011 ; 131 (4): 818-27.

2. Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell. 1975 ; 6 (3): 331-43.

3. Gómez C, Galán JM, Torrero V, Ferreiro I, Pérez D, Palao R, et al. Use of an autologous bioengineered composite skin in extensive burns: Clinical and functional outcomes. A multicentric study. Burns. 2011 ; 37 (4): 580-9.

4. Gillespie DL. Writing Group III of the Pacific Vascular Symposium 6. Venous ulcer diagnosis, treatment, and prevention of recurrences. J Vasc Surg. 2010 ; 52 Suppl 5: S8S-14S.

5. Hernández-Martín A, Torrelo A. Epidermólisis ampollosas hereditarias: del diagnóstico a la realidad. Actas Dermosifiliogr. 2010 ; 101 (6): 495-505.

6. Peña I, Junquera LM, Meana Á, García E, Aguilar C, Fresno MF. In vivo behavior of complete human oral mucosa equivalents: characterization in athymic mice. J Periodontal Res. 2011 ; 46 (2): 214-20.

7. Gallico G, O´Connor E, Compton C, Remensnyder J, Kehinde O, Green H. Cultured epitelial autografts for giant congenital nevi. J Plast Reconstr Surg. 1989 ; 84: 1-9.

8. Meana A, Iglesias J, Del Rio M, Larcher F, Madrigal B, Fresno MF, et al. Large surface of cultured human epithelium obtained on a dermal matrix base on live fibroblast-containing fibrin gels. Burns. 1998 ; 24 (7): 621-30.

9. Arvelo F, Pérez P, Cotte C. Obtención de láminas de piel humana mediante ingeniería de tejidos. Acta Científica Venezolana. 2004 ; 55 (1): 74-82.

10. Gragnani A, Müller BR, Silva ID, Noronha SM, Ferreira LM. Keratinocyte growth factor, tumor necrosis factor-alpha and interleukin-1 beta gene expression in cultured fibroblasts and keratinocytes from burned patients. Acta Cir Bras. 2013 ; 28 (8): 551-8.

11. Martínez-Santamaría L, Guerrero-Aspizua S, Del Río M. Skin bioengineering: preclinical and clinical applications. Actas Dermosifiliogr. 2012; 103 (1): 5-11.

12. Falanga V, Margolis D, Alvarez O, Auletta M, Maggiacomo F, Altman M, et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogenic cultures human skin equivalent. Arch Dermatol. 1998 ; 134 (3): 293-300.

13. Ehrlich H. Understanding experimental biology of skin equivalent: from laboratory to clinical use in patients with burns and chronic wounds. Am J Surg. 2004 ; 187 (5A): 29S-33S.

14. Llames S, García E, Otero Hernández J, Meana A. Tissue bioengineering and artificial organs. Adv Exp Med Biol. 2012 ; 741: 314-36.